Plain-English translation of NCT06515717 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a supplement called ketone ester to understand how it affects your mood, thinking, and metabolism. You would take the medication three times a day for one week, while researchers measure changes in your behavior and cognition. This is early-stage research designed to explore how this treatment works in the body.
Ketones are a natural fuel source your body can use, and researchers want to understand whether this medication might influence brain function and behavior in meaningful ways. This foundational research may help inform future health applications.
You would visit the lab four times over about two weeks: on day one and day eight of each treatment phase. At each visit, you would complete thinking and behavior tasks, answer questionnaires, provide blood samples, and have blood work done. Between visits, you would take the medication or placebo three times daily, track your food using an app, and collect stool samples. The study uses a crossover design, meaning you'll try both the ketone supplement and a matched placebo (fake) version to see if there are any differences.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Germany
Sponsor
German Institute of Human Nutrition
Enrollment target
~45 participants
Started
July 2024
Primary completion
June 2025
Age range
18 Years – 45 Years
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Beatrix Keweloh
German Institute of Human Nutrition